Phase 2b clinical trial in collaboration with Professor Shabir Madhi and Wits UniversityBill & Melinda Gates Foundation providing $15 million grant toward […]
HAIFA, Israel, Aug. 17, 2020 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a […]